Radioimmunoguided surgery using indium-111 capromab pendetide (PROSTASCINT) to diagnose supraclavicular metastasis from prostate cancer

Urology

Volumn 56, Issue 4, 2000, Pages 669-

  Anderson, R Scott ^d   Eifert, Brian ^b   Tartt, Stephen ^c   King, Paul ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Jeff Anderson Regl Medical Center   (United States)

^c Medical Arts Surgical Group   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; CAPROMAB PENDETIDE IN 111;

ADULT; ARTICLE; CASE REPORT; DRUG DISTRIBUTION; DRUG UPTAKE; GAMMA SCINTIGRAPHY; HUMAN; HUMAN TISSUE; LUNG HILUS; LYMPHADENECTOMY; MALE; MESENTERY LYMPH NODE; METASTASIS; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUPRACLAVICULAR FOSSA;

EID: 0343789652     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0090-4295(00)00715-9     Document Type: Article

References (12)

1. Pilepich M.V., Krall J.M., John M.J., et al. Extended field (periaortic) irradiation in carcinoma of the prostate analysis of RTOG 75-06 . Int J Radiat Oncol Biol Phys. 12:1986;345-351.
2. Bagshaw M.A., Ray G.R., Cox R.S. Radiotherapy of prostatic carcinoma long- or short-term efficacy (Stanford University Experience) . Urology. 25:1985;17-23.
3. Lopes A.D., Davis W.L., Rosenstraus M.J., et al. Immunohistochemical and pharmacokinetic characterization of the site-specific immunoconjugate CYT-356 derived from antiprostate monoclonal antibody 7E11-C5. Cancer Res. 50:1990;6423-6429.
4. Wright G.I., Haley C., Beckett M.I., et al. Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues. Urol Oncol. 1:1995;18-28.
5. Kocher DC: Radioactive decay tables. U.S. Department of Energy Technical Information Center, Publication No. DOE/TIC-11026, 1981, p 115.
6. Manyak M.J., Hinkle G.H., Olssen J.O., et al. Immunoscintigraphy with indium-111-capromab pendetide evaluation before definitive therapy in patients with prostate cancer . Urology. 54:1999;1058-1063.
7. Saitoh H., Yoshida K., Uchijima Y., et al. Two different lymph node metastatic patterns of a prostatic cancer. Cancer. 65:1990;1843-1846.
8. Martin E.W., Mojzisik C.M., Hinkle G.H., et al. Radioimmunoguided surgery using monoclonal antibody. Am J Surg. 156:1988;386-392.
9. Badellino F., Bertaglio S., Mariana G., et al. Use of radioimmunoguided surgery after induction chemotherapy in locally advanced breast cancer. Semin Surg Oncol. 15:1998;245-248.
10. Grazia M., Bini A., Stella F., et al. Radioimmunoguided surgery and intraoperative lung cancer staging. Semin Surg Oncol. 15:1998;215-219.
11. Badalament R.A., Burgers J.K., Petty L.R., et al. Radioimmunoguided radical prostatectomy and lymphadenectomy. Cancer. 71:1993;2268-2275.
12. Cytogen Corporation, Princeton, NJ: ProstaScint Kit (capromab pendetide) package insert, 1997.